Assessing Leadership Styles on Pharmacovigilance Team Performance Outcomes

Certificate: View Certificate

Published Paper PDF: View PDF

DOI: https://doi.org/10.63345/ijrmp.v14.i9.3

Dr Munish Kumar

K L E F Deemed To Be University

Green Fields, Vaddeswaram, Andhra Pradesh 522302, India

engg.munishkumar@gmail.com

Abstract

This study examines the influence of leadership styles on performance outcomes within pharmacovigilance teams operating in biopharmaceutical organizations. Specifically, transformational, transactional, and laissez-faire leadership styles are analyzed to determine their associations with key performance indicators (KPIs) such as adverse event reporting quality, response timeliness, regulatory compliance, and team job satisfaction. Employing a convergent mixed-methods design, quantitative data were collected via standardized surveys (n = 220 pharmacovigilance professionals) and archival performance records over a 12‑month period. Qualitative insights were gleaned from semi‑structured interviews with 20 team members and managers. Statistical analyses—including multiple regression and ANOVA—assessed the predictive strength of each leadership style on performance metrics, while thematic analysis of interview transcripts identified underlying mechanisms. Findings indicate that transformational leadership significantly predicts higher reporting accuracy (β = 0.42, p < .001), faster case processing times (F[2,217] = 8.37, p = .0004), and enhanced team satisfaction (β = 0.47, p < .001). Transactional leadership shows moderate positive effects on regulatory compliance rates (β = 0.28, p = .003) but negligible impact on innovation or discretionary effort. Laissez‑faire leadership correlates with lower overall performance and increased error rates. This research underscores the critical role of transformational leadership behaviors—such as inspirational motivation and individualized consideration—in optimizing pharmacovigilance outcomes. Recommendations include targeted leadership development programs and organizational policy adjustments to foster transformational practices.

Keywords

Transformational; transactional; laissez‑faire; pharmacovigilance; team performance; adverse event reporting; regulatory compliance; leadership development

References

• https://www.researchgate.net/publication/295828057/figure/fig1/AS:470933396824064@1489290679922/Flowchart-of-transformational-program-in-tempering.png
• https://globalinx.co.jp/wp-content/uploads/2018/08/Build-a-Leadership-Program-Page-Head.jpg
• Avolio, B. J., & Bass, B. M. (1995). Individual consideration viewed at multiple levels of analysis: A multi‑level framework for examining the diffusion of transformational leadership. The Leadership Quarterly, 6(2), 199–218.
• Avolio, B. J., Bass, B. M., & Jung, D. I. (1999). Re‑examining the components of transformational and transactional leadership using the Multifactor Leadership Questionnaire. Journal of Occupational and Organizational Psychology, 72(4), 441–462.
• Bass, B. M., & Avolio, B. J. (1994). Improving organizational effectiveness through transformational leadership. Sage Publications.
• Bass, B. M., & Riggio, R. E. (2006). Transformational leadership (2nd ed.). Lawrence Erlbaum Associates.
• Boamah, S. A., Spence Laschinger, H. K., Wong, C., & Clarke, S. (2018). Effect of transformational leadership on job satisfaction and patient safety outcomes. Nursing Outlook, 66(2), 180–189.
• Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101.
• Frankel, A., Leonard, M., & Denham, C. (2006). Fair and just culture, team behavior, and leadership engagement: The tools to achieve high reliability. Health Services Research, 41(4 Pt 2), 1690–1709.
• Hazell, L., & Shakir, S. (2006). Under‑reporting of adverse drug reactions: A systematic review. Drug Safety, 29(5), 385–396.
• Hofmann, D. A., & Morgeson, F. P. (1999). Safety‑related behavior as a social exchange: The role of perceived organizational support and leader‑member exchange. Journal of Applied Psychology, 84(2), 286–296.
• Judge, T. A., & Piccolo, R. F. (2004). Transformational and transactional leadership: A meta‑analytic test of their relative validity. Journal of Applied Psychology, 89(5), 755–768.
• Khalili, A. (2016). Linking transformational leadership, creativity, innovation, and innovation‑supportive climate. Management Decision, 54(9), 2277–2293.
• Leung, L. H. T. (2008). Leadership and teamwork in healthcare from the perspective of theory X and theory Y. The Journal of Health Organization and Management, 22(6), 615–632.
• Nembhard, I. M., & Edmondson, A. C. (2006). Making it safe: The effects of leader inclusiveness and professional status on psychological safety and improvement efforts in health care teams. Journal of Organizational Behavior, 27(7), 941–966.
• Nilsson, M., Harr, A., & Ekesbo, R. (2014). Pharmacovigilance risk management plans: Current practice and future potential. Pharmacoepidemiology and Drug Safety, 23(7), 706–713.
• Pires, M. M., & Stanton, N. A. (2017). Exploring the impact of leadership on safety in healthcare: A systematic review. Safety Science, 95, 87–99.
• Skogstad, A., Einarsen, S., Torsheim, T., Aasland, M. S., & Hetland, H. (2007). The destructiveness of laissez‑faire leadership behavior. Journal of Occupational Health Psychology, 12(1), 80–92.
• Spector, P. E. (1997). Job Satisfaction: Application, Assessment, Cause, and Consequences. Sage Publications.
• Sweeney, J. M., & Summers, J. O. (2002). The effects of transformational leadership on organizational outcomes: An integrative review. Journal of Organizational Culture, Communications and Conflict, 6(1), 7–20.
• Tomenson, B. (2019). Building a culture of safety: Role of leadership and employee engagement in healthcare. Journal of Health Management, 21(3), 301–314.
• Wong, C. A., & Cummings, G. G. (2007). The relationship between nursing leadership and patient outcomes: A systematic review. Journal of Nursing Management, 15(5), 508–521.